Related Experiment Video
Updated: Oct 7, 2025

10:15
The Use of the Ex Vivo Chandler Loop Apparatus to Assess the Biocompatibility of Modified Polymeric Blood Conduits
Published on: August 20, 2014
11.8K
Surface Biochemical Modification of Poly(dimethylsiloxane) for Specific Immune Cytokine Response
Etienne Laborie1,2, Fabien Bayle1, David Bouville1
1Center for Nanosciences and Nanotechnologies, CNRS, Université Paris-Sud, Université Paris-Saclay, 10 Boulevard Thomas Gobert, 91120 Palaiseau, France.
ACS Applied Bio Materials
|January 11, 2022
Summary
This study developed a novel polydimethylsiloxane (PDMS)-based biosensor for detecting human tumor necrosis factor α (TNF-α). This non-invasive biosensor offers a promising tool for monitoring inflammatory diseases through simple biofunctionalization.
Area of Science:
- Biomaterials Science
- Biosensor Technology
- Immunology
Background:
- Proinflammatory cytokines, like tumor necrosis factor α (TNF-α), are implicated in various inflammatory diseases including COVID-19, sepsis, and cancer.
- Non-invasive biosensors for continuous monitoring of TNF-α in biological fluids, such as sweat, are needed for early disease detection and management.
- Polydimethylsiloxane (PDMS)-based platforms offer potential for developing such advanced biosensing devices.
Purpose of the Study:
- To develop and optimize a biofunctionalization process for PDMS surfaces for the creation of a human TNF-α biosensor.
- To establish reliable methods for characterizing the biofunctionalized PDMS surface.
- To demonstrate the efficacy of the developed biosensor in detecting and quantifying human TNF-α.
Main Methods:
- PDMS surfaces were biofunctionalized using a silanization reaction with 3-aminopropyltriethoxysilane.
- Surface characterization involved water contact angle measurements, electron dispersive X-ray, and Fourier transform infrared spectroscopy.
- An ELISA-type immunoassay with fluorescent microscopy was employed for TNF-α detection and quantification.
Main Results:
- Optimal silanization conditions were identified, ensuring a stable and reproducible aminosilane layer on PDMS surfaces.
- The developed biosensor successfully detected and quantified human TNF-α.
- A limit of detection of 0.55 μg/mL (31.6 nM) for TNF-α was achieved.
Conclusions:
- A novel, rapid, stable, and simple biofunctionalization method for PDMS-based TNF-α biosensors was successfully developed.
- This PDMS-based biosensor represents a promising non-invasive tool for monitoring TNF-α levels in biological fluids.
- The findings pave the way for continuous monitoring of inflammatory conditions through advanced biosensor technology.

